Prohance Multipack (gadoteridol)
Intravenous Vial (Ml)
Last reviewed · Source: First Databank (FDB) drug data
Overview
USES: This medication is used before a magnetic resonance imaging (MRI) scan. It belongs to a class of drugs known as gadolinium-based contrast agents (GBCAs). This medication helps the MRI scan make clearer images, so your doctor can more easily diagnose your condition.
Generic name: gadoteridol
Therapeutic class: Diagnostic Agents
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Prohance Multipack
Indications
The following indications are listed for Prohance Multipack:
- Diagnostic Imaging
Also known as: Diagnostic Imaging Exam, Diagnostic Imaging Procedure, Diagnostic Radiography, Diagnostic Radiology.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
- Acute renal failure
- Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min
- Nephrogenic systemic fibrosis
- Kidney disease with likely reduction in glomerular filtration rate (GFr)
- Asthma
Adverse reactions
There is no enhanced messaging for this drug.
Less Frequent
- Dyspnea
Rare or Very Rare
- Acute pancreatitis
- Acute renal failure
- Acute respiratory distress syndrome
- Acute respiratory failure
- Anaphylaxis
- Angina
- Angioedema
- Atrioventricular block
- Bradycardia
- Bronchospastic pulmonary disease
- Cardiac arrhythmia
- Extravasation injury
- Facial edema
- Fatigue
- Hypersensitivity drug reaction
- Hypertension
- Hypoglycemic disorder
- Hypotension
- Increased alanine transaminase
- Increased aspartate transaminase
- Laryngeal edema
- Nephrogenic systemic fibrosis
- Pulmonary edema
- Seizure disorder
- Tachycardia
- Tongue swelling
More Frequent
- Dysgeusia
- Nausea
- Vomiting
Less Frequent
- Acute cognitive impairment
- Diarrhea
- Dizziness
- Headache disorder
- Injection site erythema
- Injection site pain
- Pruritus of skin
- Symptoms of anxiety
- Urticaria
Rare or Very Rare
- Acute abdominal pain
- Anorexia
- Back pain
- Chest discomfort
- Eye tearing
- Eyelid edema
- Fever
- General weakness
- Gingival pain
- Gingivitis
- Injection site sequelae
- Muscle rigidity
- Ocular itching
- Oral pruritus
- Pain
- Palpitations
- Paresthesia
- Rhinitis
- Sensation of warmth
- Skin rash
- Syncope
- Tinnitus
- Tremor
- Vasodilation of blood vessels
- Xerostomia
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.